Table 4.

Action plan for closing the gaps.

Teams	Members	Online phase	On-site phase
Supervisory team	HCG, India	(i) Overall planning and coordination of the SCT program	(i) Febrile neutropenia policy
	(i) BMT program director
	MNH, Tanzania
	(i) Head of department of haematology and BMT	(i) Importing drugs, reagents and consumables	(i) Coordination between collaborating departments such as the clinical laboratory, transfusion medicine, dietetics, etc
	(ii) Senior consultant
	(iii) Head of nursing
	(iv) Clinical pharmacologist
	(v) Head of stem cell laboratory
Nursing	HCG, India	(i) Hand hygiene	(i) Rounding
	(i) Head of Haematology-BMT nursing	(ii) Sterile reconstitution of injectable drugs	(ii) Clinical nursing in a SCT unit
	(ii) Nursing educator, haematology-BMT	(iii) PICC line sampling and dressing
	(iii) Quality manager, haematology-BMT	(iv) Nursing monitoring
	MNH, Tanzania
	(i) Nursing head, haematology
	(ii) Nursing team, haematology
Physicians team	HCG, India	(i) Overview of SCT	(i) Patient monitoring and documentation
	(i) BMT program director	(ii) Rounding
	(ii) One attending physician	(iii) Screening patients pretransplant
	(iii) BMT coordinator	(iv) Evaluation and consenting
	MNH, Tanzania
	(i) Head of department of haematology and BMT
	(ii) All the physicians in Haematology-BMT
Stem cell laboratory	HCG, India	(i) Apheresis training	(i) Stem cell product labelling, storage and transport
	(i) Director, stem cell laboratory	(ii) CD34+ cell enumeration
	(ii) Apheresis technologist
	(iii) Hematopathologist
	(iv) Technologist, hematopathology laboratory
	MNH, Tanzania
	(i) Director, stem cell laboratory
	(ii) Apheresis technologist
	(iii) Hematopathologist
	(iv) Technologist, hematopathology laboratory